Polymorphisms in nucleotide excision repair genes and risk of multiple primary melanoma: the Genes Environment and Melanoma Study

被引:79
作者
Millikan, RC
Hummer, A
Begg, C
Player, J
de Cotret, AR
Winkel, S
Mohrenweiser, H
Thomas, N
Armstrong, B
Kricker, A
Marrett, LD
Gruber, SB
Culver, HA
Zanetti, R
Gallagher, RP
Dwyer, T
Rebbeck, TR
Busam, K
From, L
Mujumdar, U
Berwick, M
机构
[1] Univ N Carolina, Sch Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27599 USA
[2] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[3] Univ New Mexico, Albuquerque, NM 87131 USA
[4] Univ Calif Irvine, Irvine, CA USA
[5] Univ Sydney, Sydney, NSW 2006, Australia
[6] Cancercare Ontario, Toronto, ON, Canada
[7] Univ Michigan, Ann Arbor, MI 48109 USA
[8] Ctr Prevenzione Oncol, Turin, PIemonte, Italy
[9] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada
[10] Royal Childrens Hosp, Parkville, Vic 3052, Australia
[11] Univ Penn, Philadelphia, PA 19104 USA
[12] Womens Coll Hosp, Toronto, ON M5S 1B2, Canada
关键词
D O I
10.1093/carcin/bgi252
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Polymorphisms in six genes involved in nucleotide excision repair of DNA were examined in a large population-based case-control study of melanoma. Genotyping was conducted for 2485 patients with a single primary melanoma (controls) and 1238 patients with second or higher order primary melanomas (cases). Patients were ascertained from nine geographic regions in Australia, Canada, Italy and the United States. Positive associations were observed for XPD 312 Asn/Asn versus Asp/Asp [odds ratio (OR) = 1.5, 95% confidence interval (CI) 1.2-1.9] and XPD 751 Gln/Gln versus Lys/Lys (OR = 1.4, 95% CI 1.1-1.7) genotypes and melanoma. The combined XPD Asn (A) 312 + Gln (C) 751 haplotype was significantly more frequent in cases (32%) compared with controls (29%) (P = 0.003) and risk of melanoma increased significantly with one and two copies of the haplotype (ORs 1.2, 95% CI 1.0-1.4, and 1.6, 95% CI 1.2-2.0, trend P = 0.002). No significant associations were observed for HR23B codon 249, XPG codon 1104, XPC codon 939, XPF codon 415, XPF nt 2063, ERCC6 codon 1213 or ERCC6 codon 1230. ORs for XPD and XPC genotypes were stronger for melanoma diagnosed at an early age, but tests for interaction were not statistically significant. The results provide further evidence for a role of XPD in the etiology of melanoma.
引用
收藏
页码:610 / 618
页数:9
相关论文
共 56 条
[1]   Effect of XPD/ERCC2 polymorphisms on chromosome aberration frequencies in smokers and on sensitivity to the mutagenic tobacco-specific nitrosamine NNK [J].
Affatato, AA ;
Wolfe, KJ ;
Lopez, MS ;
Hallberg, C ;
Ammenheuser, MM ;
Abdel-Rahman, SZ .
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2004, 44 (01) :65-73
[2]   XPD gene polymorphism and host characteristics in the association with cutaneous malignant melanoma risk [J].
Baccarelli, A ;
Calista, D ;
Minghetti, P ;
Marinelli, B ;
Albetti, B ;
Tseng, T ;
Hedayati, M ;
Grossman, L ;
Landi, G ;
Struewing, JP ;
Landi, MT .
BRITISH JOURNAL OF CANCER, 2004, 90 (02) :497-502
[3]  
Begg CB, 1997, CANCER EPIDEM BIOMAR, V6, P99
[4]   ERCC2/XPD gene polymorphisms and lung cancer:: A HuGE review [J].
Benhamou, S ;
Sarasin, A .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2005, 161 (01) :1-14
[5]   Markers of DNA repair and susceptibility to cancer in humans: An epidemiologic review [J].
Berwick, M ;
Vineis, P .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (11) :874-897
[6]  
BERWICK M, 1998, CUTANEOUS MELANOMA, P551
[7]   No association between three xeroderma pigmentosum group C and one group G gene polymorphisms and risk of cutaneous melanoma [J].
Blankenburg, S ;
König, IR ;
Moessner, R ;
Laspe, P ;
Thoms, KM ;
Krueger, U ;
Khan, SG ;
Westphal, G ;
Volkenandt, M ;
Neumann, C ;
Ziegler, A ;
Kraemer, KH ;
Reich, K ;
Emmert, S .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2005, 13 (02) :253-255
[8]   Assessment of 3 xeroderma pigmentosum group C gene polymorphisms and risk of cutaneous melanoma:: a case-control study [J].
Blankenburg, S ;
König, IR ;
Moessner, R ;
Laspe, P ;
Thoms, KM ;
Krueger, U ;
Khan, SG ;
Westphal, G ;
Berking, C ;
Volkenandt, M ;
Reich, K ;
Neumann, C ;
Ziegler, A ;
Kraemer, KH ;
Emmert, S .
CARCINOGENESIS, 2005, 26 (06) :1085-1090
[9]   CSB is a component of RNA pol I transcription [J].
Bradsher, J ;
Auriol, J ;
de Santis, LP ;
Iben, S ;
Vonesch, JL ;
Grummt, I ;
Egly, JM .
MOLECULAR CELL, 2002, 10 (04) :819-829
[10]  
Brewster AM, 2004, CANCER EPIDEM BIOMAR, V13, P1271